Insulin therapy and risk of prostate cancer: a systematic review and meta-analysis of observational studies.
BACKGROUND: Previous observational studies have shown that insulin therapy may modify the risk of prostate cancer (PCa). However, these studies yielded controversial results. Thus, we performed this meta-analysis to determine whether insulin use was associated with PCa risk in patients with diabetes...
Main Authors: | Yan-bo Chen, Qi Chen, Zhong Wang, Juan Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3839878?pdf=render |
Similar Items
-
Coffee consumption and risk of prostate cancer: a systematic review and meta-analysis
by: Xiaonan Chen, et al.
Published: (2021-02-01) -
Photodynamic therapy for prostate cancer: a systematic review and meta-analysis
by: Lang Wang, et al.
Published: (2019-09-01) -
Neoadjuvant hormone therapy for patients with high-risk prostate cancer: a systematic review and meta-analysis
by: Wen Liu, et al.
Published: (2021-01-01) -
Insulin resistance and endometrial cancer risk: A systematic review and meta-analysis
by: Hernandez, Adrian V., et al.
Published: (2017) -
Insulin resistance and endometrial cancer risk: A systematic review and meta-analysis
by: Hernández, Adrian V., et al.
Published: (2015)